Line
|
Candle
1D
5D
1M
3M
6M
YTD
1Y
5Y
High
8.410
Open
7.825
VWAP
7.95
Vol
21.93M
Mkt Cap
335.48M
Low
7.4206
Amount
174.38M
EV/EBITDA(TTM)
--
Total Shares
20.82M
EV
342.53M
EV/OCF(TTM)
--
P/S(TTM)
0.35
Upexi, Inc. is a solana-focused treasury company. The Company is a brand owner specializing in the development, manufacturing and distribution of consumer products with diversification into the cryptocurrency space. The Company’s brands include Lucky Tail, PRAX, and Cure Mushrooms. Lucky Tail is a pet care product brand that provides products from grooming tools to nutritional products. Cure Mushrooms is a full line of medicinal mushroom products, designed by effect for consumers, which offers mushroom extracts in tinctures and gummies. PRAX is a full line of medicinal mushroom products, designed by effect for consumers, which are cultivated, extracted, and produced in the United States. Its products are distributed in the United States of America and internationally through multiple entities and managed through locations in Florida.
Show More
1 Analyst Rating
111.64% Upside
Wall Street analysts forecast UPXI stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for UPXI is 16.00 USD with a low forecast of 16.00 USD and a high forecast of 16.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
1 Buy
0 Hold
0 Sell
Moderate Buy
111.64% Upside
Current: 7.560
Low
16.00
Averages
16.00
High
16.00
111.64% Upside
Current: 7.560
Low
16.00
Averages
16.00
High
16.00
Cantor Fitzgerald
Neutral -> Overweight
upgrade
$16
2025-06-17
Reason
Cantor Fitzgerald
Price Target
$16
2025-06-17
upgrade
Neutral -> Overweight
Reason
Cantor Fitzgerald upgraded Upexi to Overweight from Neutral with a $16 price target.
See All Ratings
Valuation Metrics
The current forward P/E ratio for Upexi Inc (UPXI.O) is -62.44, compared to its 5-year average forward P/E of -0.63. For a more detailed relative valuation and DCF analysis to assess Upexi Inc 's fair value, click here.
Forward PE
The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
N/A
5Y Average PE
-0.63
Current PE
-62.44
Overvalued PE
24.41
Undervalued PE
-25.68
Forward EV/EBITDA
The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
N/A
5Y Average EV/EBITDA
-239.66
Current EV/EBITDA
-364.93
Overvalued EV/EBITDA
953.43
Undervalued EV/EBITDA
-1432.74
Forward PS
The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
N/A
5Y Average PS
1.23
Current PS
12.17
Overvalued PS
3.72
Undervalued PS
-1.26
Financials
Annual
Quarterly
FY2025Q3
YoY :
-39.49%
3.16M
Total Revenue
FY2025Q3
YoY :
-23.54%
-3.85M
Operating Profit
FY2025Q3
YoY :
-10.55%
-3.83M
Net Income after Tax
FY2025Q3
YoY :
-28.78%
-2.87
EPS - Diluted
FY2025Q3
YoY :
-59.97%
-859.30K
Free Cash Flow
FY2025Q3
YoY :
+304.96%
42.44
Gross Profit Margin - %
FY2025Q3
YoY :
+1.61%
-35.31
FCF Margin - %
FY2025Q3
YoY :
+327.35%
-121.24
Net Margin - %
Trading Trends
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
0.0
USD
0
6-9
Months
0.0
USD
0
0-12
Months
0.0
USD
0
Bought
0-3
5
997.8K
USD
Months
3-6
3
2.1M
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
Hedge Fund
Hedge Funds are Neutral. There are no significant trading trends over the last quarter.
Sold
0-3
Months
0.0
Volume
0
3-6
Months
0.0
Volume
0
6-9
Months
0.0
Volume
0
0-12
Months
0.0
Volume
0
Bought
0-3
0
0.0
Volume
Months
3-6
0
0.0
Volume
Months
6-9
0
0.0
Volume
Months
0-12
0
0.0
Volume
Months
Congress Trading
Congress are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
0.0
USD
0
6-9
Months
0.0
USD
0
0-12
Months
0.0
USD
0
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
0.0
USD
0
6-9
Months
0.0
USD
0
0-12
Months
0.0
USD
0
Bought
0-3
5
997.8K
USD
Months
3-6
3
2.1M
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
UPXI News & Events
Events Timeline
2025-08-12 (ET)
2025-08-12
08:18:15
Upexi establishes Advisory Committee, welcomes Hayes as first member
2025-08-05 (ET)
2025-08-05
08:29:01
Upexi surpasses 2M Solana in treasury
2025-07-28 (ET)
2025-07-28
08:05:20
Upexi announces $500M equity line agreement for Solana treasury
Sign Up For More Events
Sign Up For More Events
News
7.5
08-12NewsfilterUpexi Establishes Advisory Committee and Welcomes Arthur Hayes as First Member
9.0
08-11PRnewswireSHAREHOLDER ALERT: Purcell & Lefkowitz LLP Announces Shareholder Investigation of Upexi, Inc. (NASDAQ: UPXI)
8.5
08-05NewsfilterUpexi Surpasses 2 Million SOL in its Treasury
Sign Up For More News
People Also Watch
MYSZ
My Size Inc
1.270
USD
-1.01%
SNOA
Sonoma Pharmaceuticals Inc
3.000
USD
0.00%
ZVSA
Zyversa Therapeutics Inc
0.277
USD
-76.45%
ENVB
Enveric Biosciences Inc
1.060
USD
-0.93%
INM
InMed Pharmaceuticals Inc
2.210
USD
0.00%
ASTI
Ascent Solar Technologies Inc
2.140
USD
-3.17%
NBY
NovaBay Pharmaceuticals Inc
0.590
USD
+0.85%
NIVF
NewGenIvf Group Ltd
1.820
USD
-7.14%
FAQ
What is Upexi Inc (UPXI) stock price today?
The current price of UPXI is 7.56 USD — it has increased 13.51 % in the last trading day.
What is Upexi Inc (UPXI)'s business?
What is the price predicton of UPXI Stock?
What is Upexi Inc (UPXI)'s revenue for the last quarter?
What is Upexi Inc (UPXI)'s earnings per share (EPS) for the last quarter?
What changes have occurred in the market's expectations for Upexi Inc (UPXI)'s fundamentals?
How many employees does Upexi Inc (UPXI). have?